Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
INDP Indaptus Therapeutics
2.340
-0.160-6.40%
Post Mkt Price
2.3400.0000.00%
YOY
Do not show
Hide blank lines
(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31
Assets
Current assets
Cash, cash equivalents and short term investments
94.29% 33.01M -- 36.18M 2289.75% 39.13M 2289.75% 39.13M
-Cash and cash equivalents
-16.08% 14.26M -- 33.22M 2289.75% 39.13M 2289.75% 39.13M
-Short-term investments
-- 18.75M -- 2.96M -- -- -- --
Receivables
-- 0 -- 0 -- 21.06K -- 21.06K
-Other receivables
-- -- -- -- -- 21.06K -- 21.06K
Prepaid assets
-67.43% 260.88K -- 741.95K 1048.78% 1.09M 1048.78% 1.09M
Total current assets
77.06% 33.27M -- 36.92M 2231.83% 40.39M 2231.83% 40.39M
Non current assets
Net PPE
-- 127.59K -- 150.37K 12716.01% 172.89K 12716.01% 172.89K
-Gross PPE
-- 127.59K -- 150.37K 12716.01% 172.89K 12716.01% 172.89K
Other non current assets
-49.3% 659.05K -- 16.48K -62.93% 16.48K -62.93% 16.48K
Total non current assets
-39.49% 786.63K -- 166.85K 313.51% 189.37K 313.51% 189.37K
Total assets
69.52% 34.06M -- 37.09M 2182.41% 40.58M 2182.41% 40.58M
Liabilities
Current liabilities
Payables
-33.18% 2.5M -- 2.88M 1591.37% 2.64M 1591.37% 2.64M
-accounts payable
512.78% 2.43M -- 2.83M 1591.37% 2.64M 1591.37% 2.64M
-Total tax payable
-- 64.47K -- 50K -- -- -- --
Current accrued expenses
-51.27% 522.86K -- 421.5K 105.74% 498.73K 105.74% 498.73K
Current debt and capital lease obligation
-84.46% 97.91K -- 97.19K -- 96.47K -- 96.47K
-Current capital lease obligation
-84.46% 97.91K -- 97.19K -- 96.47K -- 96.47K
Current liabilities
-33.38% 3.62M -- 3.68M 128.44% 4.6M 128.44% 4.6M
Non current liabilities
Long term debt and capital lease obligation
-- 27.91K -- 50.52K -- 72.86K -- 72.86K
-Long term capital lease obligation
-- 27.91K -- 50.52K -- 72.86K -- 72.86K
Total non current liabilities
-96.1% 27.91K -- 50.52K -- 72.86K -- 72.86K
Total liabilities
-40.68% 3.65M -- 3.73M 132.05% 4.68M 132.05% 4.68M
Shareholders'equity
Share capital
-88.64% 82.59K -- 82.59K 197.01% 82.59K 197.01% 82.59K
-common stock
-88.64% 82.59K -- 82.59K 324.67% 82.59K 324.67% 82.59K
-Preferred stock
-- -- -- -- -- 0 -- 0
Retained earnings
89.37% -22.87M -- -19.04M -96.88% -15.67M -96.88% -15.67M
Paid-in capital
-76.7% 53.22M -- 52.32M 569.2% 51.49M 569.2% 51.49M
Gains losses not affecting retained earnings
-- -26.94K -- -9.22K -- -- -- --
Total stockholders'equity
118.19% 30.41M -- 33.36M 15202.83% 35.9M 15202.83% 35.9M
Total equity
118.19% 30.41M -- 33.36M 15202.83% 35.9M 15202.83% 35.9M
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
----Unqualified Opinion--

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Intec Parent, Inc. develops pharmaceutical products. The company is headquartered in Jerusalem, Israel.
CEO: Mr. Jeffrey A. Meckler
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...